Catalyst Pharmaceuticals Inc (CPRX)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	86,812	75,921	138,211	120,081	101,838	83,779	72,681	59,950	52,385	48,261	45,961	40,405	41,304	40,693	42,834	43,511	31,823	8,973	-13,055	-30,350
Revenue (ttm)	US$ in thousands	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994	102,306	72,683	41,786	12,948
Operating profit margin		21.80%	21.79%	45.62%	46.82%	47.54%	43.69%	42.64%	39.00%	37.20%	36.14%	36.22%	33.63%	34.69%	34.43%	35.77%	36.57%	31.11%	12.35%	-31.24%	-234.40%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $86,812K ÷ $398,204K
= 21.80%

The operating profit margin of Catalyst Pharmaceuticals Inc has shown fluctuations over the past few quarters, ranging from -234.40% to 47.54%. In the most recent quarter, the operating profit margin was 21.80%, indicating that the company generated $0.218 in operating profit for every dollar of sales. This represents a decrease compared to the previous quarter's operating profit margin of 21.79%.

It is important to note that the operating profit margin is a key indicator of a company's operational efficiency and profitability. A higher operating profit margin suggests that the company is effective in controlling its production and operating costs relative to its revenue. Monitoring the trend of the operating profit margin can help assess the company's financial health and management effectiveness over time.